KN-62 CAS: 127191-97-3
MF: C38H35N5O6S2
KN-62 is a potent and selective inhibitor of CaMKII.

KN-62 (CAS 127191-97-3)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 117ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
KN-62 is rated 4.5 out of 5 by 2.
loading
5
1
4
1
3
0
2
0
1
0
別名: 1-[N,O-Bis(5-Isoquinolinesulfonyl)-N-Methyltyrosyl]-4-Phenylpiperazine
アプリケーション: KN-62 is a potent and selective inhibitor of CaMKII
CAS 番号: 127191-97-3
Purity: ≥95%
Molecular Weight: 721.84
Molecular Formula: C38H35N5O6S2
試験・研究用以外には使用しないでください。 臨床及び体外診断には使用できません。
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

KN-62 has demonstrated potent and selective inhibition of Ca2+/calmodulin-dependent protein kinase II (CaMKII; Ki=0.9 μM) which causes cells to arrest in the S phase. In HEK-293 cells expressing type III adenylyl cyclase (III-AC), 10 μM of KN-62 blocked CaMKII phosphorylation of III-AC, and inhibited hormone-stimulated Ca2+ oscillations. Additionally, KN-62 is a potent non-competitive antagonist at the P2X7 receptor (IC50 = 15 nM).


参考文献

1. Tokumitsu, H., et al. 1990. J. Biol. Chem. 265: 4315-4320. PMID: 2155222
2. Minami, H., et al. 1994. Biochem. Biophys. Res. Commun. 199: 241-248. PMID: 8123019
3. Wei, J., et al. 1996. J. Biol. Chem. 271: 24231-24235. PMID: 8798667

用法 :
Following reconstitution, store in the refrigerator (4°C). Stock solutions are stable for up to 4 months at 4°C.
Physical State :
Solid
Solubility :
Soluble in 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin (0.93 mg/ml), methanol (10 mg/ml), DMSO (12 mg/ml), chloroform (20 mg/ml), ethanol (~1 mg/ml), 1:2 DMF:PBS (pH 7.2) (~0.3 mg/ml), and DMF & DMSO (~30 mg/ml).
保存方法 :
Store at -20° C
Melting Point :
130° C
Boiling Point :
~964.7° C at 760 mmHg (Predicted)
Density :
~1.4 g/cm3 (Predicted)
Refractive Index :
n20D 1.69
IC50 :
CaM kinase II : IC50 = 0.9 µM; P2X7 receptor: IC50 = 15 nM
試験・研究用以外には使用しないでください。 臨床及び体外診断には使用できません。
WGK Germany :
3
RTECS :
NX4899725
PubChem CID :
MDL Number :
MFCD00083180
SMILES :
CN([[email protected]@H](CC1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C(=O)N4CCN(CC4)C5=CC=CC=C5)S(=O)(=O)C6=CC=CC7=C6C=CN=C7

Download SDS (MSDS)

分析表

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

KN-62 (CAS 127191-97-3)  参考文献

他の人がKN-62 (CAS 127191-97-3)をどのように使用したかをご覧ください。 エントリをクリックして、PubMedエントリを表示します。 .

引用 1 to 10 of 19 合計

PMID: # 31170267  Lin, L.|Xu, L.|Lv, W.|Han, L.|Xiang, Y.|Fu, L.|Jin, M.|Zhou, R.|Chen, H.|Zhang, A.| et al. 2019. PLoS Pathog. 15: e1007795.

PMID: # 30597405  Tadić, V.|Adam, A.|Goldhammer, N.|Lautenschlaeger, J.|Oberstadt, M.|Malci, A.|Le, TT.|Sengupta, S.|Stubendorff, B.|Keiner, S.|Witte, OW.|Grosskreutz, J.| et al. 2019. Neurobiol. Aging. 75: 209-222.

PMID: # 27965148  Saito, K. et al. 2017. Toxicol In Vitro. 40: 11-25.

PMID: # 28387756  González-Juarbe, N. et al. 2017. Cell Death Differ. 24: 917-928.

PMID: # 26361762  Qiu, Y. et al. 2016. Cell. Mol. Life Sci. 73: 1067-84.

PMID: # 26327597  Estruch, M. et al. 2015. Biochimica et biophysica acta. 1851: 1442-9.

PMID: # 24372548  Rossi, C. et al. 2014. Eur. J. Clin. Invest. 44: 295-302.

PMID: # 23765195  Hurtado-Carneiro, V. et al. 2013. Mol Neurobiol. 48: 904-920.

PMID: # 22311299  Hurtado-Carneiro V. et al. 2012. Mol Neurobiol. 45(2): 348-361.

PMID: # 18577589  Wayman, GA. et al. 2008. Proc. Natl. Acad. Sci. U.S.A. 105: 9093-9098.

引用 1 to 10 of 19 合計
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 121ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 11ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;